Physician profile
Eric Krivitsky
NPI 1528245701
$9,037.79
in general payments reported to CMS, 2019-2025
44 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,649 · 2020: $1,305 · 2021: $1,182 · 2022: $531 · 2023: $2,443 · 2024: $1,184 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,219 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,218.91 |
| Travel and Lodging | $1,152.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,557.13 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Biosense Webster, INC. | $614.32 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Medtronic Vascular, INC. | $599.22 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $563.11 | 2019-2024 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $441.58 | 2019-2025 | Lifevest |
| Abbott Laboratories | $430.61 | 2020-2024 | Agilis Hispro, Jot Dx, Perclose Prostyle |
| Acutus Medical, INC. | $363.72 | 2020 | |
| Janssen Pharmaceuticals, INC | $349.78 | 2019-2024 | Xarelto |
| Amgen INC. | $323.22 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $285.92 | 2019-2025 | |
| Philips North America LLC | $266.09 | 2019-2024 | (5044) Mcot, (5050) Extended Holter |
| Biotronik INC. | $251.32 | 2019-2022 | |
| Boston Scientific Corporation | $233.81 | 2020-2025 | Emblem Mri S-Icd, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.01 | 2019-2024 | Jardiance |
| Pfizer INC. | $183.80 | 2019-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $151.27 | 2024 | Carto 3 |
| Amarin Pharma, INC. | $150.33 | 2019-2021 | |
| Edwards Lifesciences Corporation | $140.03 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $116.52 | 2019-2025 | Wainua |
| Cardiva Medical, INC. | $98.89 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Sanofi-Aventis U.S. LLC | $84.18 | 2019-2021 | |
| Bardy Diagnostics, INC. | $65.61 | 2019-2021 | |
| Abiomed | $61.39 | 2024 | Impella |
| Novo Nordisk INC | $57.36 | 2020-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $39.17 | 2021-2024 | Verquvo |
| Atricure, INC. | $37.73 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Heartflow, INC. | $37.58 | 2024-2025 | |
| Braemar Manufacturing, LLC | $32.53 | 2019 | |
| Penumbra, INC. | $31.39 | 2025 | Penumbra System |
| Ethicon US, LLC | $29.01 | 2023 | Vistaseal |
| Regeneron Healthcare Solutions, INC. | $28.78 | 2019 | |
| Cvrx, INC. | $26.63 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $22.75 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $18.88 | 2020 | |
| Daiichi Sankyo INC. | $18.47 | 2021 | |
| Elutia, INC. | $15.15 | 2021 | |
| Impulse Dynamics (USA) INC. | $14.75 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $13.65 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $13.36 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $12.76 | 2019 | |
| Medicomp INC | $12.59 | 2019 | |
| Altathera Pharmaceuticals LLC | $10.61 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Krivitsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.